New cervical cancer vaccine to be added to national immunisation schedules from Jan 1, 2027
Singaporean and permanent resident females aged 9 to 26 will have access to broader protection against cervical cancer from Jan 1, 2027, when a new vaccine is added to the national immunisation schedules.In a joint statement on Friday (Oct 2), the Ministry of Health (MOH), Communicable Diseases Agency and Health Promotion Board said the HPV9 vaccine, also known as Gardasil 9, will be included in the National Childhood Immunisation Schedule (NCIS) and National Adult Immunisation Schedule (NAIS). Currently, the HPV2 vaccine, also known as Cervarix, is included in both schedules and will remain available as an alternative option when HPV9 is added.Both vaccines protect against HPV strains that cause about 70 per cent of cervical cancers. However, the agencies noted that the HPV9 vaccine provides broader protection by also covering additional HPV types that account for a further 20 per cent of cervical cancers, bringing its total coverage to about 90 per cent.